Home
Market Capitalization of Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
Market Cap
Key Highlights
- The Market Cap of Venmax Drugs & Pharmaceuticals Ltd is ₹ 12.48 crore as of 21 Feb 25 .
- The Latest Trading Price of Venmax Drugs & Pharmaceuticals Ltd is ₹ 23.81 as of 21 Feb 15:30 .

Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
Share Price
Market Price of Venmax Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 23.81 |
20 Feb 2025 | 24.29 |
19 Feb 2025 | 24.78 |
18 Feb 2025 | 25.28 |
17 Feb 2025 | 25.79 |
14 Feb 2025 | 26.31 |
13 Feb 2025 | 26.84 |
12 Feb 2025 | 27.38 |
11 Feb 2025 | 27.93 |
10 Feb 2025 | 28.5 |
SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd
BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Venmax Drugs & Pharmaceuticals Ltd
Historical P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Venmax Drugs & Pharmaceuticals Ltd
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Venmax Drugs & Pharmaceuticals Ltd
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Dividend Payout Over Time
About Venmax Drugs & Pharmaceuticals Ltd
- Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998.
- The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
- It became a Public Limited Company on February 3, 1995 with 'Yenkey Drugs & Pharmaceuticals Limited'.
- Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
- Initially, the Company engaged in the business of pharmaceutical products, drug intermediaries & API's etc.
Venmax Drugs & Pharmaceuticals Ltd News Hub
Venmax Drugs & Pharmaceuticals to conduct board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au
Read more
16 Aug 24
Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J
Read more
13 Aug 24
Venmax Drugs & Pharmaceuticals to hold board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au
Read more
03 Aug 24
Venmax Drugs & Pharmaceuticals to hold AGM
Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w
Read more
27 Aug 24